Key facts
- Matoke Holdings’s last known valuation is $26.1M (Feb 2026).
- It has raised $17.7M; the latest was Later Stage VC ($15.7M) in Feb 2026.
- Notable investors include The BioHub Birmingham.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Matoke Holdings
- ·The full record, as it builds
Funding rounds
No funding rounds for Matoke Holdings are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Matoke Holdings
Developer of reactive oxygen delivery systems intended for wound care and infection control. The company offers clinicians treating acute, surgical, and chronic wounds, to control potential and actual infections, biofilm and positively driving wound repair, providing patients with wound infection control and healing technology.
- Sector
- Healthcare
- HQ
- Southmoor, United Kingdom
- Founded
- 2010
- Employees
- 19
- Website
- matokeholdings.com/
- Ownership
- Privately Held (backing)
Matoke Holdings doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Matoke Holdings shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Matoke Holdings in its N-PORT filings yet. We sweep new filings monthly.